1.375GBp+5.77%Mkt Cap: 22.08M GBpP/E: —Last update: 2026-06-01
genedrive plc engages in the design, development, and manufacture of molecular diagnostics testing equipment for use in genotyping, pathogen detection, infectious disease detection, and other clinical indications. The co…
Industry Peers
Diagnostics & Research183.26BUSDP/E 27.1
127.46BUSDP/E 35.0
45.09BUSDP/E 42.1
38.48BUSDP/E 27.4
37.00BUSDP/E 47.9
34.66BCHFP/E 38.1
31.51BUSD—
31.45BUSDP/E 23.4
Indicators:|
Key Statistics
Company
Market Cap22.08M GBp
Enterprise Value13.50M GBp
Revenue (TTM)1.17M GBp
Gross Profit-3.33M GBp
Net Income (TTM)-5.23M GBp
Revenue/Share0.0020 GBp
Last Price1.375 GBp
Fiscal Year EndJun 2025
MR QuarterDec 2025
Employees43
CountryGB
SectorHealthcare
IndustryDiagnostics & Research
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)0.01
PEG—
EV/EBITDA-2.51
EV/Revenue11.50
P/S17.78
P/B—
EPS (TTM)-0.01
EPS (Forward)2.10
52W Range
0.190084% of range1.600
52W High1.600 GBp
52W Low0.1900 GBp
Profitability
Gross Margin-283.99%
Oper. Margin-459.47%
EBITDA Margin0.00%
Profit Margin-684.69%
ROE-363.77%
ROA-185.83%
Growth
Revenue Growth62.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF-5.14M GBp
CapEx (TTM)23.00K GBp
FCF Margin-173.52%
FCF Yield-9.23%
Net Debt113.00K GBp
Net Debt/EBITDA-0.02
Balance Sheet
Debt/Equity0.00
Current Ratio0.99
Quick Ratio0.78
Book Value/Sh0.0000 GBp
Cash/Share0.0000 GBp
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 GBp
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.1.61B
Float564.81M
Insiders63.18%
Institutions1.33%
Technical
SMA 501.008 (+36.4%)
SMA 2000.8614 (+59.6%)
Beta0.92
S&P 52W Chg27.94%
Avg Vol (30d)9.73M
Avg Vol (10d)8.49M
Technical Indicators
RSI (14)76.4
MACD0.0712
MACD Signal0.0465
MACD Hist.+0.0248
BB Upper1.305 GBp
BB Middle1.082 GBp
BB Lower0.8600 GBp
BB Width41.09%
ATR (14)0.1293 GBp
Vol Ratio (20d)0.63x